Opus Genetics (IRD) FCF Margin (2020 - 2026)
Opus Genetics (IRD) reported FCF Margin of 590.03% for Q1 2026, down 38422.0% year-over-year from N/an in Q1 2025, and down 131.92% quarter-over-quarter from 254.41% in Q4 2025.
Opus Genetics (IRD) FCF Margin (2020 - 2026) Analysis & Trends
Opus Genetics (IRD) has 7 years of FCF Margin data on file, last reported at 590.03% in Q1 2026.
- FCF Margin for Q1 2026 came in at 590.03%, down 38422.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 325.34% (down 11398.0% YoY), and the FY2025 annual result was 248.33%, down 1565.0% from the prior year.
- FCF Margin fell to 590.03% in Q1 2026 per IRD's latest filing, from 254.41% in the prior quarter.
- Over five years, FCF Margin peaked at 268.95% in Q4 2023 and troughed at 655.76% in Q2 2024.
- A 5-year average of 197.67% and a median of 202.89% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin slumped 68267 bps in 2024, then soared 29944 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 72.25% in 2022, then surged by 272 bps to 268.95% in 2023, then tumbled by 164 bps to 172.9% in 2024, then sank by 47 bps to 254.41% in 2025, then sank by 132 bps to 590.03% in 2026.
- Business Quant data shows IRD's FCF Margin at 590.03% in Q1 2026, 254.41% in Q4 2025, and 199.97% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Opus Genetics | 355.39 Mn | 295.43 Mn | - | -590.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -590.03% |
| Dec 31, 2025 | -254.41% |
| Sep 30, 2025 | -199.97% |
| Jun 30, 2025 | -356.32% |
| Mar 31, 2025 | -205.81% |
| Dec 31, 2024 | -172.90% |
| Sep 30, 2024 | -132.66% |
| Jun 30, 2024 | -655.76% |
| Mar 31, 2024 | -334.07% |
| Dec 31, 2023 | 268.95% |
| Sep 30, 2023 | -25.16% |
| Jun 30, 2023 | 26.92% |
| Mar 31, 2023 | -208.46% |
| Dec 31, 2022 | 72.25% |
| Sep 30, 2021 | -732.92% |
| Jun 30, 2021 | -4,328.00% |
| Mar 31, 2020 | -63.65% |